​

Equillium (EQ) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

EQ Stock Forecast

Equillium (EQ) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $1.00, with a high of $1.00 and a low of $1.00. This represents a 122.22% increase from the last price of $0.45.

High: $1 Avg: $1 Low: $1 Last Closed Price: $0.45

EQ Stock Rating

Equillium stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (81.82%), 2 Hold (18.18%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 2 9 Strong Sell Sell Hold Buy Strong Buy

EQ Price Target Upside V Benchmarks

TypeNameUpside
StockEquillium122.22%
SectorHealthcare Stocks 18.80%
IndustryBiotech Stocks 54.28%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$1.00
Last Closing Price$0.45$0.45$0.45
Upside/Downside--122.22%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 25--2--2
Jun, 25--2--2
May, 25--2--2
Apr, 25--2--2
Mar, 25-11--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 28, 2025Thomas SmithLeerink Partners$1.00$0.40150.00%122.22%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 02, 2024H.C. WainwrightBuyBuyhold
Dec 26, 2023CitigroupBuyBuyhold
Feb 08, 2023SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-4 $2 $8 $14 $20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.19$-0.38$-0.23----
Avg Forecast$-1.67$-0.50$-0.55$-1.21$-1.20$-0.62$-0.13
High Forecast$-1.67$-0.42$16.90$-0.74$-1.20$-0.62$-0.13
Low Forecast$-1.67$-0.62$-9.27$-1.45$-1.20$-0.62$-0.13
Surprise %91.02%-24.00%-58.18%----

Revenue Forecast

$10M $25M $40M $55M $70M $85M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.76M$36.08M$41.09M----
Avg Forecast$18.00M$33.37M$31.85M$11.00M$15.58M$48.72M$84.11M
High Forecast$18.00M$36.99M$39.94M$11.00M$15.58M$48.72M$84.11M
Low Forecast$18.00M$27.46M$23.76M$11.00M$15.58M$48.72M$84.11M
Surprise %-12.45%8.14%29.03%----

Net Income Forecast

$-350M $-160M $30M $220M $410M $600M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-107.71M$-13.34M$-8.07M----
Avg Forecast$-57.99M$-18.07M$-4.62M$-40.63M$-41.67M$-21.53M$-4.51M
High Forecast$-57.99M$-14.53M$586.70M$-25.81M$-41.67M$-21.53M$-4.51M
Low Forecast$-57.99M$-21.62M$-321.74M$-50.29M$-41.67M$-21.53M$-4.51M
Surprise %85.72%-26.21%74.80%----

EQ Forecast FAQ

Is Equillium stock a buy?

Equillium stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Equillium is a favorable investment for most analysts.

What is Equillium's price target?

Equillium's price target, set by 11 Wall Street analysts, averages $1 over the next 12 months. The price target range spans from $1 at the low end to $1 at the high end, suggesting a potential 122.22% change from the previous closing price of $0.45.

How does Equillium stock forecast compare to its benchmarks?

Equillium's stock forecast shows a 122.22% upside, outperforming the average forecast for the healthcare stocks sector (18.80%) and outperforming the biotech stocks industry (54.28%).

What is the breakdown of analyst ratings for Equillium over the past three months?

  • July 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Equillium’s EPS forecast?

Equillium's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.21, marking a 426.09% increase from the reported $-0.23 in 2024. Estimates for the following years are $-1.2 in 2026, $-0.62 in 2027, and $-0.13 in 2028.

What is Equillium’s revenue forecast?

Equillium's average annual revenue forecast for its fiscal year ending in December 2025 is $11M, reflecting a -73.23% decrease from the reported $41.1M in 2024. The forecast for 2026 is $15.58M, followed by $48.72M for 2027, and $84.11M for 2028.

What is Equillium’s net income forecast?

Equillium's net income forecast for the fiscal year ending in December 2025 stands at $-40.626M, representing an 403.61% increase from the reported $-8.067M in 2024. Projections indicate $-41.672M in 2026, $-21.53M in 2027, and $-4.514M in 2028.